New single-cell analysis reveals clonal heterogeneity in pancreatic ductal adenocarcinoma driving therapy resistance and immune evasion.
New single-cell analysis reveals clonal heterogeneity in pancreatic ductal adenocarcinoma driving therapy resistance and immune evasion.